A Study of KK2269 in Adult Participants With Solid Tumors

NCT06266299 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Metastatic Solid Tumor
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Non Small Cell Lung Cancer

Interventions

DRUG: KK2269
DRUG: Docetaxel

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]